Sandra Lee is CEO of NJ Labs (New Brunswick, NJ), a nationally recognized provider and advocate for quality in chemistry and microbiology testing that serves the pharmaceutical, nutraceutical, dietary supplement, cosmetic, and cannabis/CBD industries. As a scientist and one of the few female CEOs in the analytical testing industry, she has a passion for chemistry and how it influences multiple aspects of our daily lives. NJ Labs’ team of scientists is continually developing and validating methods for raw materials and finished products testing. NJ Labs is at the unique intersection between servicing dietary supplements and pharmaceutical drugs, which allows it to offer its clients a wide range of comprehensive testing and services. Prior to leading NJ Labs, Lee worked in many scientific roles at both Cardinal Health and Pfizer where she recognized the importance of uncompromising quality through chemistry, not only from the company’s perspective but also from the consumer’s perspective of product safety and public health needs. At NJ Labs, she leads the privately owned FDA- and DEA-inspected facility that has been a mainstay in the testing industry for 85 years with a certified, full-service contract analytical testing laboratory that follows strict current Good Manufacturing Practice (cGMP) regulations and holds ISO/IEC 17025:2017 accreditation. To help clients remain innovative and competitive while still meeting rigorous compliance requirements, Lee continues to expand the expertise of NJ Labs while developing quality systems grounded in transparency, integrity, and expertise. Lee is a graduate of the University of Michigan where she holds a Bachelor of Science degree in Chemistry.